Organon & Co.OGNNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank61
3Y CAGR-11.0%
5Y CAGR-5.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-11.0%/yr
Quarterly compound
5Y CAGR
-5.6%/yr
Recent deceleration
Percentile
P61
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 8.33% |
| Q3 2025 | -11.58% |
| Q2 2025 | -1.04% |
| Q1 2025 | -26.15% |
| Q4 2024 | 17.12% |
| Q3 2024 | -4.31% |
| Q2 2024 | 3.57% |
| Q1 2024 | -16.42% |
| Q4 2023 | -2.19% |
| Q3 2023 | 7.03% |
| Q2 2023 | -0.78% |
| Q1 2023 | -9.15% |
| Q4 2022 | 11.81% |
| Q3 2022 | 19.81% |
| Q2 2022 | 10.42% |
| Q1 2022 | -12.73% |
| Q4 2021 | -0.90% |
| Q3 2021 | 46.05% |
| Q2 2021 | 13.43% |
| Q1 2021 | 11.67% |
| Q4 2020 | 11.11% |
| Q3 2020 | 5.88% |
| Q2 2020 | 13.33% |
| Q1 2020 | 0.00% |